{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T14:37:48Z","timestamp":1778855868452,"version":"3.51.4"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,8]],"date-time":"2022-06-08T00:00:00Z","timestamp":1654646400000},"content-version":"vor","delay-in-days":1529,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100007659","name":"Bayer Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","exphem.org","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Hematology"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.exphem.2018.01.002","type":"journal-article","created":{"date-parts":[[2018,1,11]],"date-time":"2018-01-11T19:00:33Z","timestamp":1515697233000},"page":"73-82.e3","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Blockade of placental growth factor reduces vaso-occlusive complications in murine models of sickle cell disease"],"prefix":"10.1016","volume":"60","author":[{"given":"Jian-Ming","family":"Gu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shujun","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Derek","family":"Sim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keith","family":"Abe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Perry","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Rosenbruch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Bringmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katalin","family":"Kauser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.exphem.2018.01.002_bib0010","doi-asserted-by":"crossref","first-page":"4331","DOI":"10.1182\/blood-2010-01-251348","article-title":"The inherited diseases of hemoglobin are an emerging global health burden","volume":"115","author":"Weatherall","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2018.01.002_bib0015","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1056\/NEJM199709113371107","article-title":"Pathogenesis and treatment of sickle cell disease","volume":"337","author":"Bunn","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.exphem.2018.01.002_bib0020","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1006\/jmbi.1997.1253","article-title":"The high resolution crystal structure of deoxyhemoglobin S","volume":"272","author":"Harrington","year":"1997","journal-title":"J Mol Biol"},{"key":"10.1016\/j.exphem.2018.01.002_bib0025","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1172\/JCI111234","article-title":"Static and dynamic rigidities of normal and sickle erythrocytes. Major influence of cell hemoglobin concentration","volume":"73","author":"Evans","year":"1984","journal-title":"J Clin Invest"},{"key":"10.1016\/j.exphem.2018.01.002_bib0030","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1097\/00062752-200203000-00003","article-title":"Sickle cell vaso-occlusion: multistep and multicellular paradigm","volume":"9","author":"Frenette","year":"2002","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.exphem.2018.01.002_bib0035","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1172\/JCI118355","article-title":"In vivo demonstration of red cell\u2013endothelial interaction, sickling and altered microvascular response to oxygen in the sickle transgenic mouse","volume":"96","author":"Kaul","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1016\/j.exphem.2018.01.002_bib0040","doi-asserted-by":"crossref","first-page":"3356","DOI":"10.1073\/pnas.86.9.3356","article-title":"Microvascular sites and characteristics of sickle cell adhesion to vascular endothelium in shear flow conditions: pathophysiological implications","volume":"86","author":"Kaul","year":"1989","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.exphem.2018.01.002_bib0045","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1146\/annurev-bioeng-070909-105339","article-title":"Sickle cell biomechanics","volume":"12","author":"Barabino","year":"2010","journal-title":"Annu Rev Biomed Eng"},{"key":"10.1016\/j.exphem.2018.01.002_bib0050","first-page":"449","article-title":"Sickle cell disease patients' perceptions of emergency department pain management","volume":"104","author":"Porter","year":"2012","journal-title":"J Natl Med Assoc"},{"key":"10.1016\/j.exphem.2018.01.002_bib0055","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1182\/blood.V89.5.1787","article-title":"Acute chest syndrome in sickle cell disease: clinical presentation and course. Cooperative Study of Sickle Cell Disease","volume":"89","author":"Vichinsky","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2018.01.002_bib0060","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1182\/blood-2009-12-260513","article-title":"GMI-1070, a novel pan-selectin antagonist, reverses acute vascular occlusions in sickle cell mice","volume":"116","author":"Chang","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2018.01.002_bib0065","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1056\/NEJM199406093302303","article-title":"Mortality in sickle cell disease: life expectancy and risk factors for early death","volume":"330","author":"Platt","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.exphem.2018.01.002_bib0070","doi-asserted-by":"crossref","first-page":"3892","DOI":"10.1182\/blood-2013-05-498311","article-title":"Vaso-occlusion in sickle cell disease: pathophysiology and novel targeted therapies","volume":"122","author":"Manwani","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2018.01.002_bib0075","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1182\/blood-2015-09-618538","article-title":"Neutrophils, platelets, and inflammatory pathways at the nexus of sickle cell disease pathophysiology","volume":"127","author":"Zhang","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2018.01.002_bib0080","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1056\/NEJMoa1611770","article-title":"Crizanlizumab for the prevention of pain crises in sickle cell disease","volume":"376","author":"Ataga","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.exphem.2018.01.002_bib0085","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1172\/JCI77250","article-title":"Placenta growth factor augments airway hyperresponsiveness via leukotrienes and IL-13","volume":"126","author":"Eiymo Mwa Mpollo","year":"2016","journal-title":"J Clin Invest"},{"key":"10.1016\/j.exphem.2018.01.002_bib0090","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1182\/blood-2002-11-3422","article-title":"Placenta growth factor activates monocytes and correlates with sickle cell disease severity","volume":"102","author":"Perelman","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2018.01.002_bib0095","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1182\/blood-2009-09-244830","article-title":"High levels of placenta growth factor in sickle cell disease promote pulmonary hypertension","volume":"116","author":"Sundaram","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2018.01.002_bib0100","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1182\/blood-2015-09-618553","article-title":"Beyond hydroxyurea: new and old drugs in the pipeline for sickle cell disease","volume":"127","author":"Telen","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2018.01.002_bib0105","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1182\/blood-2013-11-539718","article-title":"Heme-bound iron activates placenta growth factor in erythroid cells via erythroid Kruppel-like factor","volume":"124","author":"Wang","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2018.01.002_bib0110","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1182\/blood-2009-04-217950","article-title":"Placenta growth factor in sickle cell disease: association with hemolysis and inflammation","volume":"115","author":"Brittain","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2018.01.002_bib0115","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.blre.2016.08.004","article-title":"Placental growth factor: what hematologists need to know","volume":"31","author":"Newell","year":"2017","journal-title":"Blood Rev"},{"key":"10.1016\/j.exphem.2018.01.002_bib0120","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1038\/nm884","article-title":"Role of PlGF in the intra- and intermolecular cross talk between the VEGF receptors Flt1 and Flk1","volume":"9","author":"Autiero","year":"2003","journal-title":"Nat Med"},{"key":"10.1016\/j.exphem.2018.01.002_bib0125","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/87904","article-title":"Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions","volume":"7","author":"Carmeliet","year":"2001","journal-title":"Nat Med"},{"key":"10.1016\/j.exphem.2018.01.002_bib0130","doi-asserted-by":"crossref","first-page":"17629","DOI":"10.1074\/jbc.271.30.17629","article-title":"The vascular endothelial growth factor receptor Flt-1 mediates biological activities: implications for a functional role of placenta growth factor in monocyte activation and chemotaxis","volume":"271","author":"Clauss","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1016\/j.exphem.2018.01.002_bib0135","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1038\/nm740","article-title":"Placental growth factor reconstitutes hematopoiesis by recruiting VEGFR1(+) stem cells from bone-marrow microenvironment","volume":"8","author":"Hattori","year":"2002","journal-title":"Nat Med"},{"key":"10.1016\/j.exphem.2018.01.002_bib0140","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1038\/nature04186","article-title":"VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche","volume":"438","author":"Kaplan","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2018.01.002_bib0145","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1161\/01.RES.0000057997.77714.72","article-title":"VEGFR-1-selective VEGF homologue PlGF is arteriogenic: evidence for a monocyte-mediated mechanism","volume":"92","author":"Pipp","year":"2003","journal-title":"Circ Res"},{"key":"10.1016\/j.exphem.2018.01.002_bib0150","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1182\/blood-2002-11-3423","article-title":"Mechanism of monocyte activation and expression of proinflammatory cytochemokines by placenta growth factor","volume":"102","author":"Selvaraj","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2018.01.002_bib0155","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1182\/blood-2008-07-169821","article-title":"Placenta growth factor induces 5-lipoxygenase-activating protein to increase leukotriene formation in sickle cell disease","volume":"113","author":"Patel","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2018.01.002_bib0160","doi-asserted-by":"crossref","first-page":"16713","DOI":"10.1074\/jbc.M110.101691","article-title":"Placenta growth factor (PlGF), a novel inducer of plasminogen activator inhibitor-1 (PAI-1) in sickle cell disease (SCD)","volume":"285","author":"Patel","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1016\/j.exphem.2018.01.002_bib0165","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1182\/blood-2014-06-583351","article-title":"Randomized phase 2 study of GMI-1070 in SCD: reduction in time to resolution of vaso-occlusive events and decreased opioid use","volume":"125","author":"Telen","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2018.01.002_bib0170","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/ajh.20143","article-title":"Microvascular blood flow and stasis in transgenic sickle mice: utility of a dorsal skin fold chamber for intravital microscopy","volume":"77","author":"Kalambur","year":"2004","journal-title":"Am J Hematol"},{"key":"10.1016\/j.exphem.2018.01.002_bib0175","doi-asserted-by":"crossref","first-page":"147","DOI":"10.22203\/eCM.v022a12","article-title":"The dorsal skinfold chamber: window into the dynamic interaction of biomaterials with their surrounding host tissue","volume":"22","author":"Laschke","year":"2011","journal-title":"Eur Cell Mater"},{"key":"10.1016\/j.exphem.2018.01.002_bib0180","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1182\/blood-2005-06-2373","article-title":"Lactate dehydrogenase as a biomarker of hemolysis-associated nitric oxide resistance, priapism, leg ulceration, pulmonary hypertension, and death in patients with sickle cell disease","volume":"107","author":"Kato","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2018.01.002_bib0185","doi-asserted-by":"crossref","first-page":"3382","DOI":"10.1182\/blood.V126.23.3382.3382","article-title":"Protection of microvascular liver perfusion with 5-hydroxymethylfurfural in sickle cell disease mice following hypoxia-induced vasoocclusion","volume":"126","author":"Wright","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2018.01.002_bib0190","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.1073\/pnas.052522799","article-title":"Primary role for adherent leukocytes in sickle cell vascular occlusion: a new paradigm","volume":"99","author":"Turhan","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.exphem.2018.01.002_bib0195","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0101301","article-title":"Phase 1 study of the E-selectin inhibitor GMI 1070 in patients with sickle cell anemia","volume":"9","author":"Wun","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.exphem.2018.01.002_bib0200","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.exphem.2016.06.252","article-title":"Targeting Mac-1-mediated leukocyte-RBC interactions uncouples the benefits for acute vaso-occlusion and chronic organ damage","volume":"44","author":"Chen","year":"2016","journal-title":"Exp Hematol"},{"key":"10.1016\/j.exphem.2018.01.002_bib0205","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1182\/blood-2007-12-130567","article-title":"Placenta growth factor augments endothelin-1 and endothelin-B receptor expression via hypoxia-inducible factor-1 alpha","volume":"112","author":"Patel","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2018.01.002_bib0210","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1111\/j.1398-9995.2004.00469.x","article-title":"Cytokine-regulated accumulation of eosinophils in inflammatory disease","volume":"59","author":"Lampinen","year":"2004","journal-title":"Allergy"},{"key":"10.1016\/j.exphem.2018.01.002_bib0215","doi-asserted-by":"crossref","first-page":"570","DOI":"10.3389\/fimmu.2014.00570","article-title":"Eosinophil cytokines, chemokines, and growth factors: emerging roles in immunity","volume":"5","author":"Davoine","year":"2014","journal-title":"Front Immunol"},{"key":"10.1016\/j.exphem.2018.01.002_bib0220","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1002\/1521-4141(200107)31:7<1981::AID-IMMU1981>3.0.CO;2-X","article-title":"Neutrophils produce biologically active macrophage inflammatory protein-3alpha (MIP-3alpha)\/CCL20 and MIP-3beta\/CCL19","volume":"31","author":"Scapini","year":"2001","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.exphem.2018.01.002_bib0225","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0171067","article-title":"NNKTT120, an anti-iNKT cell monoclonal antibody, produces rapid and sustained iNKT cell depletion in adults with sickle cell disease","volume":"12","author":"Field","year":"2017","journal-title":"PLoS ONE"},{"key":"10.1016\/j.exphem.2018.01.002_bib0230","doi-asserted-by":"crossref","first-page":"a011056","DOI":"10.1101\/cshperspect.a011056","article-title":"PlGF: a multitasking cytokine with disease-restricted activity","volume":"2","author":"Dewerchin","year":"2012","journal-title":"Cold Spring Harbor Perspect Med"},{"key":"10.1016\/j.exphem.2018.01.002_bib0235","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.clinthera.2011.08.007","article-title":"Monoclonal antibody TB-403: A first-in-human, phase I, double-blind, dose escalation study directed against placental growth factor in healthy male subjects","volume":"33","author":"Martinsson-Niskanen","year":"2011","journal-title":"Clin Ther"},{"key":"10.1016\/j.exphem.2018.01.002_bib0240","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.pharmthera.2016.10.016","article-title":"Monoclonal antibody therapy for the treatment of asthma and chronic obstructive pulmonary disease with eosinophilic inflammation","volume":"169","author":"Nixon","year":"2017","journal-title":"Pharmacol Ther"}],"container-title":["Experimental Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X1830002X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X1830002X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,11]],"date-time":"2022-06-11T05:33:09Z","timestamp":1654925589000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301472X1830002X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":47,"alternative-id":["S0301472X1830002X"],"URL":"https:\/\/doi.org\/10.1016\/j.exphem.2018.01.002","relation":{},"ISSN":["0301-472X"],"issn-type":[{"value":"0301-472X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Blockade of placental growth factor reduces vaso-occlusive complications in murine models of sickle cell disease","name":"articletitle","label":"Article Title"},{"value":"Experimental Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exphem.2018.01.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 ISEH \u2013 Society for Hematology and Stem Cells. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}